Skip to main content
. 2020 Dec 18;11:614256. doi: 10.3389/fimmu.2020.614256

Table 2.

Properties of the AvGn-B variants.

Clone SARS-CoV-2 RBD (EC50, nM) SARS-CoV-2 RBD (IC50, nM) Neutralizing Activity in CPE (IC50, μg/ml)
AvGn-B 0.17 2.20 0.005–0.008
AvGn-B-G2 0.09 0.26 0.00017
AvGn-B-G4 0.11 0.39 0.00064
AvGn-B-H1 0.12 0.39 0.00116
AvGn-B-H2 0.09 0.39 0.00112